Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
53.10
+1.10 (2.12%)
Sep 4, 2025, 1:30 PM CST
2.12%
Market Cap4.51B
Revenue (ttm)4.48B
Net Income (ttm)-322.97M
Shares Out86.75M
EPS (ttm)-3.72
PE Ration/a
Forward PEn/a
Dividend1.00 (1.95%)
Ex-Dividend DateJul 7, 2025
Volume513,450
Average Volume127,035
Open54.00
Previous Close52.00
Day's Range52.70 - 55.80
52-Week Range40.05 - 60.70
Beta0.24
RSI55.86
Earnings DateAug 11, 2025

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.